Sun Pharm Drug Patent Portfolio

Sun Pharm's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Novo Nordisk Focuses on Local Partnerships and Price Reductions Amidst Increasing Competition from Generic Weight-Loss Medications

05 Apr, 2026

US Drug Pricing Strategies Expected to Overlook Indian Generics, Sun Pharma Impacted Less

02 Apr, 2026

India's GLP-1 Market Conflict: Patent Expiration Triggers Price Competition | Whalesbook

31 Mar, 2026

Indian Pharmaceutical Tycoons Invest Heavily in Generic Weight-Loss Medications, Leading to Increased Regulatory Oversight

30 Mar, 2026